P-098TRYbeCA-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441). (2nd July 2019) - Hammel, P; Feliu, J; Parner, V; Berardi, R; Van Cutsem, E; Greil, R; Wasan, H; Metges, J; Nygren, P; Osterlund, P; Seufferlein, T; Creemers, G; et al.